Pfizer’s earnings crush estimates as company raises guidance

• Biogen’s stock hit by soft sales of Alzheimer’s treatment

  Business - MarketWatch - October 30

• Bristol Myers’s stock pops as earnings top estimates and company raises guidance

  Business - MarketWatch - October 31

• Lowe’s CEO confident in retailer’s ability to manage Trump tariffs after earnings beat

  Business - MarketWatch - Yesterday

• Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales

  Business - CNBC - October 29

• Merck’s stock slides as Q3 earnings beat estimates, but company lowers guidance

  Business - MarketWatch - October 31

• Freshpet’s stock jumps premarket after earnings beat and company raises guidance

  Business - MarketWatch - November 4

• Centene’s stock soars 11% after earnings sweep past estimates and company backs guidance

  Business - MarketWatch - October 25

More from MarketWatch

• Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers

  Business - MarketWatch - 18 minutes ago

• BJ’s stock surges on first membership fee increase in seven years

  Business - MarketWatch - 32 minutes ago

• Starbucks’ China business is struggling. Here’s how the company may give it a jolt.

  Business - MarketWatch - 35 minutes ago

• Temu parent’s stock tumbles after a big earnings miss as competition intensified

  Business - MarketWatch - 50 minutes ago

• Adani Group companies lose $26 billion in market value after U.S. indictment

  Business - MarketWatch - 52 minutes ago